ACTU
Actuate Therapeutics Inc
NASDAQHealthcareBiotechnologyUS
USD1.35
-0.05 (-3.57%)
Rating:C
Company Profile
CEO
Daniel Schmitt
IPO Date
2024-08-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$1.42
Prev. Close
$1.40
Day Low
$1.32
Day High
$1.50
52W Low
$1.16
52W High
$9.22
Market Cap
$0.03B
Volume
0.11M